Given that BBR has been shown to regulate Treg cells by modifying the microbiota in a chemically induced IBD model and to regulate Bcl-2 in an in vitro autoimmune disease model29,30, we next examined the change in the frequency of Foxp3+ Treg cells and the Bcl-2 expression. The gene discussed is BCL2; the disease is autoimmune disease.